Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of May 21, 2026, PDEX trades at $63.59 with a market cap of $188.88M and a P/E ratio of 18.23. PDEX moved +2.55% today. Year to date, PDEX is +63.92%; over the trailing twelve months it is +42.41%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on PDEX?
Rallies AI research for PDEX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
CABILLOT RAYMOND E sold 7.26K (~$363.22K) on Apr 1, 2025.
CABILLOT RAYMOND E sold 836 (~$41.80K) on Mar 31, 2025.
CABILLOT RAYMOND E sold 842 (~$42.10K) on Mar 28, 2025.
PDEX Analyst Consensus
PDEX analyst coverage data. Average price target: $0.00.
Common questions about PDEX
What is the AI research view on PDEX?
Rallies AI research for PDEX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for PDEX?
Rallies AI research for PDEX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is PDEX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.
